| Objective/purpose: |
Collect
supportive and pivotal data needed to establish the effectiveness
of oxytetracycline (OTC) immersion therapy to control mortality
caused by certain bacterial diseases. |
| Drug name: |
PennField Animal Health's Pennox 343® or any other brand of oxytetracycline water-soluble powder. |
| Source of drug: |
Purchase Pennox 343® from your local or regional retail outlet for OTC soluble powder (i.e., farm & ranch store, veterinary supply outlet, etc.). If not available from the retail outlet you normally use, then click here for a list of regional distributors of PennField’s Pennox 343® OTC water-soluble product. |
| Address: |
PennField Animal Health
14040 Industrial Road
Omaha, Nebraska 68144
|
| Contact: |
Mr. Greg Bergt
Phone:
800-832-83038
Fax: 402-330-6004
Email: gbergt@pennfieldanimalhealth.com
|
| Target
pathogen(s): |
Bacterial
pathogens susceptible to oxytetracycline. |
| Method
of administration: |
Immersion
treatment |
| Treatment
dosage: |
Options
A & B: single treatment of 20 milligrams OTC per liter
Options C & D: up to multiple treatments at 20 milligrams OTC per liter |
| Treatment
regimen: |
Option
A: 1-hour treatment for salmonids
Option B: 1-hour treatment for various cool and warmwater fish
Option C: 1-hour treatment on 1 to 4 consecutive days for salmonids
Option D: 1-hour treatment on 1 to 4 consecutive days for various cool and warmwater fish |
| Withdrawal
period: |
Options
A & B: 21 days. No withdrawal period is required for fish that will not be catchable for 21 or more days after release, or are illegal for harvest.
Options C & D: 60 days. No withdrawal period is required for fish that will not be catchable for 60 or more days after release, or are illegal for harvest. |
| Required
test parameters: |
Investigator
must collect mortality data throughout the 5-day pretreatment,
treatment, and 30-day posttreatment periods. Investigator should
also report general fish behavior and any adverse effects relating
to treatment. |
| Limitations
or restrictions on use: |
Investigator
must follow all instructions in the Study Protocol for INAD
9033 regarding drug acquisition and handling, fish treatment
and disposition, and data reporting requirements.
Drug discharge
must be in compliance with local NPDES permitting requirements. |
| Required
INAD fee: |
$400.00
per facility per year |
| AADAP
contact for other information: |
Ms.
Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242
bonnie_johnson@fws.gov |
| Disclaimer: |
Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government. |
|
